Fibroscan Study in HCC

Inclusion Criteria

• •Clinical diagnosis of HCC
• •Patients who are scheduled to undergo therapy, either TACE systemic therapy or surgery
• •1. For TACE cohort, patients undergoing first cycle TACE are eligible.
• •2. For systemic therapy cohort, patients undergoing first-line systemic therapy are eligible.
• •3. For surgery cohort, patient undergoing surgery are eligible.
• •Prior surgery or loco-ablative therapy (e.g. Radiofrequency ablation, microwave, percutaneous ethanol injection) is allowed
• •Child's A to Child's C liver function